{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:29:52Z","timestamp":1775194192085,"version":"3.50.1"},"reference-count":30,"publisher":"Georg Thieme Verlag KG","issue":"02","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":2239,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Nucl Med"],"published-print":{"date-parts":[[2016,4]]},"abstract":"<jats:p>Understanding the range and variability of normal, benign degenerative, and malignant 18 F sodium fluoride ( 18 F NaF) positron emission tomography\/computed tomography (PET\/CT) uptake is important in influencing clinical interpretation. Further, it is essential for the development of realistic semiautomated quantification techniques and simulation models. The purpose of this study is to determine the range of these values in a clinically relevant patient population with prostate cancer. 18 F NaF PET\/CT scans were analyzed in patients with prostate cancer (n = 47) referred for evaluation of bone metastases. Mean and maximum standardized uptake values [SUVs (SUV mean and SUV max )] were made in normal background regions (n = 470) including soft tissues (liver, aorta, bladder, adipose, brain, and paraspinal muscle) and osseous structures (T12 vertebral body, femoral diaphyseal cortex, femoral head medullary space, and ribs). Degenerative joint disease (DJD; n = 281) and bone metastases (n = 159) were identified and quantified by an experienced reader using all scan information including coregistered CT. For normal bone regions, the highest 18 F NaF PET SUV mean occurred in T12 (6.8 \u00b1 1.4) and it also showed the lowest coefficient of variation (cv = 21%). For normal soft tissues, paraspinal muscles showed very low SUV mean (0.70 \u00b1 0.11) and also showed the lowest variability (cv = 16%). Average SUV mean in metastatic lesions is higher than uptake in benign degenerative lesions but values showed a wide variance and overlapping values (16.3 \u00b1 13 vs 11.1 \u00b1 3.8; P &lt; 0.00001). The normal 18 F NaF PET uptake values for prostate cancer patients in normal background, benign degenerative disease, and osseous metastases are comparable to those reported for a general population with a wide variety of diagnoses. These normal ranges, specifically for prostate cancer patients, will aid in clinical interpretation and also help to establish the basis of normal limits in a semiautomated data analysis algorithm.<\/jats:p>","DOI":"10.4103\/1450-1147.172301","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T07:34:39Z","timestamp":1450683279000},"page":"102-108","source":"Crossref","is-referenced-by-count":30,"title":["18 F sodium fluoride PET\/CT in patients with prostate cancer: Quantification of normal tissues, benign degenerative lesions, and malignant lesions"],"prefix":"10.1055","volume":"15","author":[{"given":"Jorge","family":"Oldan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Division of Nuclear Medicine, Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Department of Radiology, Division of Nuclear Medicine, Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bennett","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Radiology, Division of Nuclear Medicine, Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"key-10.4103\/1450-1147.172301-1","first-page":"287","volume-title":"The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18f-fluoride PET, and 18F-fluoride PET\/CT","author":"Even-Sapir","year":"2006","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-2","first-page":"523","volume-title":"A meta-analysis of (18) F-Fluoride positron emission tomography for assessment of metastatic bone tumor","author":"Tateishi","year":"2010","journal-title":"Ann Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-3","first-page":"50","volume-title":"The role of positron emission tomography in skeletal disease","author":"Cook","year":"2001","journal-title":"Semin Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-4","first-page":"252","volume-title":"Prospective evaluation of (99m) Tc MDP scintigraphy, (18) F NaF PET\/CT, and (18) F FDG PET\/CT for detection of skeletal metastases","author":"Iagaru","year":"2012","journal-title":"Mol Imaging Biol"},{"key":"key-10.4103\/1450-1147.172301-5","first-page":"272","volume-title":"Assessment of malignant skeletal disease: Initial experience with 18F-fluoride PET\/CT and comparison between 18F-fluoride PET and 18F-fluoride PET\/CT","author":"Even-Sapir","year":"2004","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-6","first-page":"354","volume-title":"Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: Results from American College of Radiology imaging network 6687","author":"Yu","year":"2015","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-7","first-page":"222","volume-title":"18F-fluoride PET used for treatment monitoring of systemic cancer therapy: Results from the national oncologic PET registry","author":"Hillner","year":"2015","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-8","first-page":"574","volume-title":"Impact of 18F-fluoride PET in patients with known prostate cancer: Initial results from the national oncologic PET registry","author":"Hillner","year":"2014","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-9","first-page":"83","volume-title":"Standardized uptake value atlas: Characterization of physiological 2-deoxy-2-[18F] fluoro-d-glucose uptake in normal tissues","author":"Wang","year":"2007","journal-title":"Mol Imaging Biol"},{"key":"key-10.4103\/1450-1147.172301-10","first-page":"e228","volume-title":"18F-sodium fluoride PET\/CT in oncology: An atlas of SUVs","author":"Sabbah","year":"2014","journal-title":"Clin Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-11","first-page":"3A","volume-title":"Patient-specific model of NaF PET to facilitate multicenter clinical trial PET imaging protocols and analysis: Preliminary results of a CT-based simulation","author":"Wilson","year":"2013","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-12","first-page":"50","volume-title":"Volume-based assessment by (18) F-FDG PET\/CT predicts survival in patients with stage III non-small-cell lung cancer","author":"Hyun","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key-10.4103\/1450-1147.172301-13","first-page":"589","volume-title":"Prediction for recurrence using F-18 FDG PET\/CT in pathologic N0 lung adenocarcinoma after curative surgery","author":"Kim","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"key-10.4103\/1450-1147.172301-14","first-page":"487","volume-title":"Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning","author":"Patz","year":"1993","journal-title":"Radiology"},{"key":"key-10.4103\/1450-1147.172301-15","first-page":"275","volume-title":"Volume-based parameters measured by using FDG PET\/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: Prognostic value","author":"Satoh","year":"2014","journal-title":"Radiology"},{"key":"key-10.4103\/1450-1147.172301-16","first-page":"1075","volume-title":"Prospective investigation of positron emission tomography in lung nodules","author":"Lowe","year":"1998","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/1450-1147.172301-17","first-page":"1528","volume-title":"18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy","author":"Usmanij","year":"2013","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-18","first-page":"756","volume-title":"Do clinical characteristics and metabolic markers detected on positron emission tomography\/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?","author":"Akkas","year":"2013","journal-title":"Ann Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-19","first-page":"1254","volume-title":"New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer","author":"Melloni","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"key-10.4103\/1450-1147.172301-20","first-page":"81","volume-title":"Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline","author":"Jadvar","year":"2011","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-21","first-page":"118","volume-title":"Increasing uptake time in FDG-PET: Standardized uptake values in normal tissues at 1 versus 3 h","author":"Chin","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"key-10.4103\/1450-1147.172301-22","first-page":"1175","volume-title":"The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology","author":"Kurdziel","year":"2012","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-23","first-page":"1589","volume-title":"Assessment of blood pool, soft tissue, and skeletal uptake of sodium fluoride F 18 with positron emission tomography-computed tomography in four clinically normal dogs","author":"Valdes-Martinez","year":"2012","journal-title":"Am J Vet Res"},{"key":"key-10.4103\/1450-1147.172301-24","first-page":"1539","volume-title":"Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology","author":"Dweck","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/1450-1147.172301-25","first-page":"569","volume-title":"Association of linear 18 F-sodium fluoride accumulation in femoral arteries as a measure of diffuse calcification with cardiovascular risk factors: A PET\/CT study","author":"Janssen","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"key-10.4103\/1450-1147.172301-26","first-page":"1493","volume-title":"Comparison of different quantitative approaches to 18F-fluoride PET scans","author":"Brenner","year":"2004","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-27","first-page":"633","volume-title":"Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET","author":"Hawkins","year":"1992","journal-title":"J Nucl Med"},{"key":"key-10.4103\/1450-1147.172301-28","first-page":"763","volume-title":"Differences in skeletal kinetics between vertebral and humeral bone measured by 18f-fluoride positron emission tomography in postmenopausal women","author":"Cook","year":"2000","journal-title":"J Bone Miner Res"},{"key":"key-10.4103\/1450-1147.172301-29","doi-asserted-by":"crossref","unstructured":"Segall G, Delbeke D, Stabin MG, Even-Sapir E, Fair J, Sajdak R, et al.; SNM. SNM practice guideline for sodium 18F-fluoride PET\/CT bone scans 1.0. J Nucl Med 2010;51:1813-20.","DOI":"10.2967\/jnumed.110.082263"},{"key":"key-10.4103\/1450-1147.172301-30","first-page":"84","volume-title":"18F-fluoride PET\/CT for bone scanning.Role of attenuation correction","author":"Nagarajah","year":"2012","journal-title":"Nuklearmedizin"}],"container-title":["World Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.4103\/1450-1147.172301.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T22:34:57Z","timestamp":1652999697000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.4103\/1450-1147.172301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":30,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2022,5,19]]},"published-print":{"date-parts":[[2016,4]]}},"URL":"https:\/\/doi.org\/10.4103\/1450-1147.172301","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1450-1147","1607-3312"],"issn-type":[{"value":"1450-1147","type":"print"},{"value":"1607-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}